Morgan Stanley’s Barinthus Biotherapeutics BRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.51K | Buy |
4,852
+3,981
| +457% | +$3.7K | ﹤0.01% | 7065 |
|
|
2025
Q1 | $847 | Sell |
871
-7,150
| -89% | -$6.95K | ﹤0.01% | 7305 |
|
|
2024
Q4 | $9.69K | Sell |
8,021
-3,962
| -33% | -$4.79K | ﹤0.01% | 6815 |
|
|
2024
Q3 | $14.3K | Buy |
11,983
+3,110
| +35% | +$3.7K | ﹤0.01% | 6609 |
|
|
2024
Q2 | $12.4K | Sell |
8,873
-3,989
| -31% | -$5.59K | ﹤0.01% | 6602 |
|
|
2024
Q1 | $30.6K | Sell |
12,862
-20,072
| -61% | -$47.8K | ﹤0.01% | 6372 |
|
|
2023
Q4 | $122K | Buy |
32,934
+11,719
| +55% | +$43.2K | ﹤0.01% | 6097 |
|
|
2023
Q3 | $65.6K | Buy |
21,215
+5,768
| +37% | +$17.8K | ﹤0.01% | 6050 |
|
|
2023
Q2 | $31.8K | Sell |
15,447
-53,350
| -78% | -$110K | ﹤0.01% | 6384 |
|
|
2023
Q1 | $154K | Buy |
68,797
+56,982
| +482% | +$128K | ﹤0.01% | 5827 |
|
|
2022
Q4 | $27.8K | Sell |
11,815
-753
| -6% | -$1.77K | ﹤0.01% | 6546 |
|
|
2022
Q3 | $40K | Sell |
12,568
-1,241
| -9% | -$3.95K | ﹤0.01% | 6498 |
|
|
2022
Q2 | $61K | Buy |
13,809
+4,511
| +49% | +$19.9K | ﹤0.01% | 6519 |
|
|
2022
Q1 | $48K | Sell |
9,298
-333
| -3% | -$1.72K | ﹤0.01% | 6719 |
|
|
2021
Q4 | $107K | Sell |
9,631
-14,443
| -60% | -$160K | ﹤0.01% | 6399 |
|
|
2021
Q3 | $379K | Buy |
24,074
+7,193
| +43% | +$113K | ﹤0.01% | 5659 |
|
|
2021
Q2 | $284K | Buy |
+16,881
| New | +$284K | ﹤0.01% | 5844 |
|